Old Web
English
Sign In
Acemap
>
authorDetail
>
Dmitry Evseev
Dmitry Evseev
Langerhans cell histiocytosis
Vemurafenib
Sepsis
Internal medicine
Minimal residual disease
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discourse-Driven Integrated Dialogue Development Environment for Open-Domain Dialogue Systems
2021
| Conference on Empirical Methods in Natural Language Processing
Denis Kuznetsov
Dmitry Evseev
Lidia Ostyakova
Oleg Serikov
Daniel Kornev
Mikhail Burtsev
Show All
Source
Cite
Save
Citations (0)
Discourse-Driven Integrated Dialogue Development Environment for Open-Domain Dialogue Systems
2021
Denis Kuznetsov
Dmitry Evseev
Lidia Ostyakova
Oleg Serikov
Daniel Kornev
Mikhail S. Burtsev
Show All
Source
Cite
Save
Citations (0)
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA.
2021
International Journal of Hematology
Dmitry Evseev
Irina Kalinina
Elena Raykina
Daria Osipova
Zalina Abashidze
Anna Ignatova
Anna Mitrofanova
Alexey Maschan
Galina Novichkova
Michael Maschan
Show All
Source
Cite
Save
Citations (0)
Vemurafenib provides a rapid and robust clinical response in paediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease based on ddPCR using cell-free circulating DNA
2020
Dmitry Evseev
Irina Kalinina
Elena Raykina
Daria Osipova
Zalina Abashidze
Anna Ignatova
Anna Mitrofanova
Alexei Maschan
Galina Novichkova
Michael Maschan
Show All
Source
Cite
Save
Citations (0)
1